Cancer Immunotherapy Market Size | Industry Analysis Report, 2021

 Rosy wills
  3rd-Jul-2019
 30

According to research report Cancer Immunotherapy Market is expected to reach USD 119.39 Billion by 2021 from USD 61.97 Billion in 2016, at a CAGR of 14.0% from 2016 to 2021. Report provides a detailed overview of the major drivers, restraints, challenges, opportunities, current market trends, and strategies impacting the Cancer Immunotherapy market along with the estimates and forecasts of the revenue and market share analysis.
Read More: https://www.marketsandmarkets.com/PressReleases/cancer-immunotherapy.asp
Cancer immunotherapy drugs are designed to alter or boost the body’s natural immune response to fight cancer this market is research-driven with a high degree of dependence on the discovery of molecules that can generate an immune response against various indications.
The cancer immunotherapy market has been segmented, on the basis of product into monoclonal antibodies, immunomodulators, vaccines, and check point inhibitors. The check point inhibitors segment is estimated to witness the highest CAGR during 2016-2021. The high growth can be attributed to the benefits offered by this therapeutic drug.
The monoclonal antibody segment is expected to lead the global cancer immunotherapy market during the forecast period
Monoclonal antibodies are emerging as the most effective therapeutic agents for the treatment of malignancy. They are currently one of the largest classes of agents approved for the treatment of cancer. Several antibodies are widely adopted, owing to their lesser side effects as compared to chemotherapy. Antibodies are developed to treat several cancers such as lymphoma, leukemia, melanoma, breast cancer, and lung cancer. Cancer monoclonal antibodies are sub-segmented into naked monoclonal antibodies, conjugated monoclonal antibodies, and bispecific monoclonal antibodies.
Download Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=197577894
North America is expected to account for the largest share of the market during the forecast period
Based on regions, the global Cancer Immunotherapy market is segmented into North America, APAC, Europe and the Rest of the World (RoW). North America is expected to account for the largest share of the market during the forecast period. Growth in this regional segment is driven by factors such as increase in patient pool, and initiative taken by the government for the development of Cancer Immunotherapy.
Key players in the Cancer Immunotherapy market include Amgen (US), AstraZeneca (UK), F.Hoffman La Roche (Switzerland), BayerAG (Germany), Bristol-myers squibb(US), Eli Lilly and Company (US), Janssen Global Services, LLC (Belgium), Merck (US), Novartis (Switzerland), Pfizer (US)

Contact:
Mr. Shelly Singh
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA: 1-888-600-6441
newsletter@marketsandmarkets.com

Domain: Medical
Category: Biotech/Pharma
Posted By: Rosy wills and Contact Rosy wills

Recent Press Releases

Micro Battery Market: Growing Popula...

The overall micro battery market is estimated to grow from USD 128 million in 2019 to USD 631 million by 2025, at a CAGR of 30.4% between 2019 and 2025. The growth of this market w

15 September, 2019

Chicago Dental Arts Provides Multipl...

Chicago Dental Arts is pleased to announce it is capable of providing its patients with a vast array of cosmetic procedures, depending on their individual needs.

15 September, 2019

Bio Emulsion Polymers Market Analysi...

Bio-emulsion polymers are used in a wide variety of applications, due to their capability of offering superior performance, enhanced efficiency, and reliable nature to the final pr

15 September, 2019